Darbepoetin Alfa Once Monthly Dosing Schedule Maintains Hemoglobin Concentration Comparable to Every 2 Weeks Dosing Schedule in Advanced Chronic Kidney Disease Patients Not on Dialysis: A Multicenter, Phase 4 Study
Clinical trial NCT07025460 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07025460
- Sponsor
- Gangnam Severance Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-19
- Primary completion
- 2024-10-17
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.